Production of a platelet aggregation inhibitor, salmosin, by high cell density fermentation of recombinant Escherichia coli

J Microbiol Biotechnol. 2011 Oct;21(10):1053-6. doi: 10.4014/jmb.1105.05014.

Abstract

Optimal conditions for a high cell density fermentation were investigated in a recombinant Escherichia coli producing salmosin, a platelet aggregation inhibitor. The optimized carbon and nitrogen sources were glycerol 10 g/l, yeast extract 30 g/l, and bacto-tryptone 10 g/l, yielding the dry cell weight (DCW) of 10.61 g/l in a 500 ml flask culture. The late-stage induction with 1% L-arabinose in a 5 l jar fermentor showed the highest DCW of 65.70 g/l after 27 h of the fed-batch fermentation. Around 2,200 mg/l of the protein was expressed as an inclusion body that was then refolded to obtain the active salmosin of 96 mg/l. We also confirmed the inhibitory activity against platelet aggregation of the active salmosin from the high cell density fermentation.

Publication types

  • Evaluation Study

MeSH terms

  • Batch Cell Culture Techniques / methods*
  • Crotalid Venoms / genetics
  • Crotalid Venoms / metabolism*
  • Crotalid Venoms / pharmacology
  • Escherichia coli / genetics
  • Escherichia coli / growth & development*
  • Escherichia coli / metabolism*
  • Fermentation
  • Gene Expression
  • Humans
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / metabolism*
  • Platelet Aggregation Inhibitors / pharmacology
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology

Substances

  • Crotalid Venoms
  • Platelet Aggregation Inhibitors
  • Recombinant Proteins
  • salmosin